MedTrace Logo

CATS Tonometer IOP Reduction Latanoprost Verses Timolol

NCT04178863 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2019-11-26

No results posted yet for this study

Summary

Topical Prostaglandin Analog vs Betablocker - Corneal Biomechanical Evaluation using CATS Tonometer Prism

Conditions

  • Glaucoma; Drugs

Interventions

DEVICE

CATS Tonometer

latanoprost vs. timolol

DRUG

Latanoprost

latanoprost IOP reduction

Sponsors & Collaborators

  • Intuor Technologies, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
101 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-12-30
Completion
2019-12-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04178863 on ClinicalTrials.gov